Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Véronique Abitbol, Woo-Yun Sohn, Michael Horn & Marco Aurelio P. Safadi. (2023) Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Viola Viviani, Alessia Biolchi & Mariagrazia Pizza. (2022) Synergistic activity of antibodies in the multicomponent 4CMenB vaccine. Expert Review of Vaccines 21:5, pages 645-658.
Read now
Read now
Timo Vesikari, Jerzy Brzostek, Anitta Ahonen, Marita Paassilta, Ewa Majda-Stanislawska, Leszek Szenborn, Miia Virta, Robert Clifford, Teresa Jackowska, Murray Kimmel, Ilaria Bindi, Pavitra Keshavan, Paola Pedotti & Daniela Toneatto. (2021) Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents. Human Vaccines & Immunotherapeutics 17:11, pages 4689-4700.
Read now
Read now
Omar Rossi, Francesco Citiulo & Francesca Mancini. (2021) Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans. Human Vaccines & Immunotherapeutics 17:2, pages 601-613.
Read now
Read now
Jan Dolhain, Winnie Janssens, Vasundhara Dindore & Attila Mihalyi. (2020) Infant vaccine co-administration: review of 18 years of experience with GSK’s hexavalent vaccine co-administered with routine childhood vaccines. Expert Review of Vaccines 19:5, pages 419-443.
Read now
Read now
Rino Rappuoli, Mariagrazia Pizza, Vega Masignani & Kumaran Vadivelu. (2018) Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Review of Vaccines 17:12, pages 1111-1121.
Read now
Read now
Daniela Toneatto, Mariagrazia Pizza, Vega Masignani & Rino Rappuoli. (2017) Emerging experience with meningococcal serogroup B protein vaccines. Expert Review of Vaccines 16:5, pages 433-451.
Read now
Read now
Kate L Seib, Maria Scarselli, Maurizio Comanducci, Daniela Toneatto & Vega Masignani. (2015) Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Review of Vaccines 14:6, pages 841-859.
Read now
Read now
Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, Fang Xie, Daniela Toneatto, Igor Kohl & Peter M Dull. (2014) A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I). Human Vaccines & Immunotherapeutics 10:7, pages 1993-2004.
Read now
Read now
Articles from other publishers (25)
Leila Sadeghi, Elham Mohit, Samaneh Moallemi, Fatemeh Maghsood Ahmadi & Azam Bolhassani. (2023) Recent advances in various bio-applications of bacteria-derived outer membrane vesicles. Microbial Pathogenesis 185, pages 106440.
Crossref
Crossref
Viola Viviani, Adele Fantoni, Sara Tomei, Sara Marchi, Enrico Luzzi, Margherita Bodini, Alessandro Muzzi, Marzia M. Giuliani, Domenico Maione, Jeremy P. Derrick, Isabel Delany, Mariagrazia Pizza, Alessia Biolchi & Erika Bartolini. (2023) OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans. npj Vaccines 8:1.
Crossref
Crossref
David S. Stephens, Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2023. Plotkin's Vaccines. Plotkin's Vaccines
690
710.e7
.
Michael D. Decker, Barbara J. Howe, David P. Greenberg & Kathryn M. Edwards. 2023. Plotkin's Vaccines. Plotkin's Vaccines
225
247.e13
.
Kimberly Davis, Marta Valente Pinto, Nick J Andrews, David Goldblatt, Ray Borrow, Helen Findlow, Jo Southern, Jo Partington, Emma Plested, Sima Patel, Ann Holland, Mary Matheson, Anna England, Bassam Hallis, Elizabeth Miller & Matthew D Snape. (2021) Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. The Lancet Infectious Diseases 21:5, pages 688-696.
Crossref
Crossref
Daniel O’Connor, Marta Valente Pinto, Dylan Sheerin, Adriana Tomic, Ruth E Drury, Samuel Channon‐Wells, Ushma Galal, Christina Dold, Hannah Robinson, Simon Kerridge, Emma Plested, Harri Hughes, Lisa Stockdale, Manish Sadarangani, Matthew D Snape, Christine S Rollier, Michael Levin & Andrew J Pollard. (2020) Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine. Molecular Systems Biology 16:11.
Crossref
Crossref
Ali A Raba & Ibraheem Krebit. (2020) Definite bacterial infection in recently vaccinated febrile infants. Journal of Paediatrics and Child Health 56:6, pages 889-892.
Crossref
Crossref
Gillian Campbell, Ruth M Bland & Scott J Hendry. (2018) Fever after meningococcal B immunisation: A case series. Journal of Paediatrics and Child Health 55:8, pages 932-937.
Crossref
Crossref
Gaston De Serres, Marie-Noëlle Billard, Marie-Claude Gariépy, Marie-Claude Roy, François D. Boucher, Hélène Gagné, Sylvie Belley, Eveline Toth, Monique Landry & Danuta M. Skowronski. (2019) Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal. Vaccine 37:35, pages 4996-5002.
Crossref
Crossref
Joseline Guetsop Zafack, Alexandre Bureau, Danuta M Skowronski & Gaston De Serres. (2019) Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials. BMJ Open 9:5, pages e026953.
Crossref
Crossref
T. Tenenbaum, W. Hellenbrand & H. Schroten. (2019) Impfstoffe gegen Meningokokken für das KindesalterVaccines against meningococci for children. Monatsschrift Kinderheilkunde 167:3, pages 196-205.
Crossref
Crossref
Lee H. Harrison. 2019. Vaccinations. Vaccinations
105
129
.
Gaston De Serres, Marie-Noëlle Billard, Marie-Claude Gariépy, Isabelle Rouleau, Eveline Toth, Monique Landry, Nicole Boulianne, Hélène Gagné, Vladimir Gilca, Geneviève Deceuninck, Manale Ouakki & Danuta M Skowronski. (2018) Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada. Vaccine 36:52, pages 8039-8046.
Crossref
Crossref
Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine 36:50, pages 7609-7617.
Crossref
Crossref
Dirk Mentzer, Doris Oberle & Brigitte Keller-Stanislawski. (2018) Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016. Eurosurveillance 23:17.
Crossref
Crossref
Maria Elena Flacco, Lamberto Manzoli, Annalisa Rosso, Carolina Marzuillo, Mauro Bergamini, Armando Stefanati, Rosario Cultrera, Paolo Villari, Walter Ricciardi, John P A Ioannidis & Despina G Contopoulos-Ioannidis. (2018) Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. The Lancet Infectious Diseases 18:4, pages 461-472.
Crossref
Crossref
Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2018. Plotkin's Vaccines. Plotkin's Vaccines
644
662.e6
.
Federico Martinón-Torres, Marco Aurelio P. Safadi, Alfonso Carmona Martinez, Pilar Infante Marquez, Juan Carlos Tejedor Torres, Lily Yin Weckx, Edson Duarte MoreiraJuniorJunior, Ilhem Mensi, Marco Calabresi & Daniela Toneatto. (2017) Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial. Vaccine 35:28, pages 3548-3557.
Crossref
Crossref
Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte MoreiraJuniorJunior, Eduardo Jorge da Fonseca Lima, Ilhem Mensi, Marco Calabresi & Daniela Toneatto. (2017) Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial. Vaccine 35:16, pages 2052-2059.
Crossref
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
307
334
.
Wiebke Hellenbrand, Judith Koch, Thomas Harder, Christian Bogdan, Ulrich Heininger, Tobias Tenenbaum, Martin Terhardt, Ulrich Vogel, Ole Wichmann & Rüdiger von Kries. (2015) Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal diseaseWissenschaftliche Begründung zur Aktualisierung der Meningokokken-Impfempfehlung – Anwendung des Meningokokken-B-Impfstoffs bei Personen mit erhöhtem Risiko für Meningokokken-Erkrankungen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58:11-12, pages 1314-1343.
Crossref
Crossref
Timo Vesikari, Roman Prymula, Elizabeth Merrall, Igor Kohl, Daniela Toneatto & Peter M. Dull. (2015) Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children. Vaccine 33:32, pages 3850-3858.
Crossref
Crossref
Stan L. Block, Leszek Szenborn, Wendy Daly, Teresa Jackowska, Diego D’Agostino, Linda Han, Peter M. Dull & Igor Smolenov. (2015) A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial. Vaccine 33:21, pages 2500-2510.
Crossref
Crossref
Christine Robin, Florence Beckerich & Catherine Cordonnier. (2015) Immunization in cancer patients: Where we stand. Pharmacological Research 92, pages 23-30.
Crossref
Crossref
Susanna Esposito, Claudia Tagliabue & Samantha Bosis. (2015) Meningococcal B Vaccination (4CMenB) in Infants and Toddlers. Journal of Immunology Research 2015, pages 1-6.
Crossref
Crossref